Evidence map›Paper›PMID 35127166›Full record

ArticleJournal of advanced research2022

Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors.

Yongjun Guan, Man Li, Zhendong Qiu, Junhui Xu, Yichao Zhang, Ning Hu, Xuanzhe Zhang, Wenyi Guo, Jingping Yuan, Qiao Shi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of advanced research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. DOKing tumor progression in ccRCC.Journal of Cancer · 2024
    Article
  12. Review
  13. Article
  14. Expression and clinical significance of DOK3 in renal clear cell carcinoma.The Journal of international medical research · 2023
    Article
  15. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yongjun GuanDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Man LiDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zhendong QiuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Junhui XuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Yichao ZhangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Ning HuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Xuanzhe ZhangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Wenyi GuoDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Jingping YuanDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Qiao ShiDepartment of Pancreatic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Weixing WangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Objectives: We conducted a comprehensive analysis of Methods: We used the TCGA database to analyze the correlation between Results: We conducted a comprehensive analysis of Conclusions:

Indexed as

NeoplasmsPharmaceutical PreparationsGenes, NeoplasmHumansPrognosisTumor MicroenvironmentPharmaceutical PreparationsDOKDrug sensitivityImmune infiltrationTumor microenvironment

Identifiers

PMID35127166
PMCPMC8799871
OpenAlexW3168943842

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.